[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
March 4, 1998

Promotional Practices of Pharmacy Benefits Management Companies

Author Affiliations

Not Available

Not Available

JAMA. 1998;279(9):645. doi:10.1001/jama.279.9.645

The FDA has announced the availability of a draft guidance for industry entitled, "Promoting Medical Products in a Changing Healthcare Environment: Medical Product Promotion by Healthcare Organizations or Pharmacy Benefits Management Companies (PBMs)." This document provides guidance to the pharmaceutical industry and other sponsors of regulated medical products by describing circumstances in which they may be held responsible for promotional activities performed by health care organizations or PBMs.

First Page Preview View Large
First page PDF preview
First page PDF preview